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ABSTRACT 
Bone resorption is dependent on the differentiation of osteoclast (OC) 
progenitor cells from the hematopoietic lineage into mature multinucleated OCs 
with the ability to resorb mineralized bone.  Receptor activator of NF-κB ligand 
(RANKL) and macrophage-colony stimulating factor (M-CSF) are vital for 
osteoclastogenesis, while osteoprotegerin (OPG), the decoy receptor for RANKL, 
inhibits osteoclastogenesis.  These factors are produced by osteoblasts (OBs), 
which are also the bone-forming cells. Prostaglandin (PG) E2 is a potent 
stimulator of resorption.  It stimulates osteoclastogenesis by acting on OBs to 
induce RANKL and inhibit OPG expression.  Less is known about how PGE2 acts 
on the hematopoietic lineage to directly regulate osteoclastogenesis.  The goal of 
this project was to examine the effects of PGE2 on OC formation from purified 
bone marrow macrophages (BMMs) in the presence of RANKL and M-CSF.   
 BMMs were isolated from murine long bones, expanded with M-CSF in 
petri dishes, replated in 96-well plates or 48-well plates, and treated with M-CSF 
and RANKL (M+R) or M+R plus PGE2.  OCs, defined as cells with >3 nuclei 
staining for tartrate resistant acid phosphatase (TRAP), were counted in 3 wells 
per group on days 4-9 of culture.  Counting was done either directly, under the 
microscope, or indirectly, with multiple digital images pieced together to create 
one seamless image of the entire well, which was then printed out for counting.  
Comparison of direct and indirect quantification of OC counts showed a 99.8% 
correlation.  All experiments were quantified using the indirect method.  In 48-well 
plates, M+R stimulated OC formation that peaked at d 7 or 8 in 3 independent 
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experiments, and PGE2 inhibited OC formation induced by M+R at all time points 
and tended to delay the peak OC formation by 24 h.  In 96-well plates, M+R 
alone had inconsistent results.  In these 3 independent experiments the results 
showed: either stimulation, no effect leading to stimulation, or a biphasic effect 
with early inhibition and later stimulation.   The OC formation peaked at d 4, 5, or 
d 7.  Although effects of PGE2 on formation of OCs from BMMs were variable in 
96-well plates, PGE2 consistently inhibited OC formation in 48-well plates.  Our 
data suggest that direct effects of PGE2 on OC precursors may oppose the 
indirect effects of PGE2 to increase OCs via increasing RANKL in OBs. 
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INTRODUCTION 
1.  Bone Resorption – Bone resorption is the process by which mineralized 
bone is broken down, and the calcium and phosphate in the mineral matrix is 
returned to the blood.  Resorption is the first step in the bone remodeling cycle, 
which replaces “old” bone with “new” bone, and is coupled to bone formation by 
many locally produced factors, including some released from the bone matrix by 
the resorption process itself.  The bone remodeling cycle is important for mineral 
homeostasis, for repair of damaged bone, and to allow bone to change its shape 
in response to mechanical loading.  In particular, bone resorption is necessary for 
orthodontic tooth movement.   
 
Osteoclasts (OCs) 
OCs are multinucleated cells (MNCs) that resorb mineralized bone.  They 
develop from the monocyte-macrophage lineage of hematopoietic cells [1].  OCs 
express tartrate-resistant acid phosphatase (TRAP) activity and calcitonin 
receptors (CTRs).  TRAP is an enzyme identified in both the ruffled border of the 
OC membrane and in the secretions in the resorptive space [2].  TRAP is highly 
expressed by OCs, macrophages, and neurons [3].  The exact function of TRAP 
is unknown, but many functions have been attributed to this protein, such as the 
generation of reactive oxygen species, iron transport, and regulation of cell 
growth and differentiation factor [4].  The CTR is a G protein-coupled receptor 
that binds calcitonin.  CTR is more specific for OCs than TRAP [4].  Calcitonin  is 
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involved in the maintenance of calcium homeostasis and can transiently inhibit 
OC activity [1].  
 
Osteoclastogenesis 
        Cell-to-cell contact between cells of the osteoblastic lineage and OC 
progenitors is necessary for OC differentiation [5].  Osteoblasts (OBs), which are 
derived from precursors in the mesenchymal cell lineage, support OC 
development by producing macrophage/monocyte-colony stimulating factor (M-
CSF) and receptor activator of NF-κB ligand (RANKL).  OC differentiation 
involves several major stages as illustrated in Figure 1.  Hematopoietic stem cells 
(HSCs) give rise to colony forming unit-granulocyte/macrophages (CFU-GMs).  
M-CSF stimulates the proliferation of CFU-GMs into monocyte/macrophage cells 
that lack TRAP and CTR, two crucial OC markers.  Mononuclear OC precursors 
differentiate into prefusion OCs (cells positive for both TRAP and CTR) in 
response to stimulation from M-CSF and RANKL.  These factors bind their 
respective receptors, c-fms and RANK, expressed on OC precursors to stimulate 
OC formation.  The prefusion OCs will further develop and differentiate by fusion 
to become MNCs (with continuous stimulation of M-CSF and RANKL).   
Once MNCs become functional OCs, they present with a ruffled border 
and the ability to resorb mineralized bone matrix [6].  The ruffled border 
increases the surface area interface for bone resorption [7].  It also creates a 
‘Sealing Zone’ around the resorption area, allowing the enzymes to have an 
isolated area with a low pH, thus providing the OC with the proper environment 
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needed for bone mineral dissolution [8].  RANKL continues to play an important 
role in activating OCs by stimulating formation of the ruffled membrane [1]. 
RANKL may also enhance OC survival [9].   
 
RANKL and Osteoprotegerin (OPG) 
RANKL, also called osteoprotegerin ligand (OPGL) [10], is a member of 
the TNF superfamily.  It is a cell surface molecule expressed not only by OBs but 
also by marrow stromal cells and activated T lymphocytes [5].  In vitro, RANKL 
and M-CSF have been shown to be sufficient for stimulating osteoclastogenesis 
[11].  Both RANKL knockout and RANK knockout mice have osteopetrosis 
secondary to complete absence of OCs in bone [12].  OB/stromal cells also 
produce osteoprotegerin (OPG), a soluble decoy receptor for RANKL.  OPG 
inhibits RANKL function by competing with RANK for RANKL [13]. OPG knockout 
mice show decreased bone density [14] and defects in tooth eruption and 
osteoclastogenesis [14], while mice with over expression of OPG show increased 
bone density [15].   
 For some factors that stimulate resorption, such as parathyroid hormone, 
there are no known receptors on cells in the osteoclastic lineage, and their ability 
to stimulate resorption is reflected by their ability to stimulate RANKL and inhibit 
OPG (or to increase the RANKL:OPG ratio) in OBs.  Other factors, such as 
prostaglandins, have receptors on OCs as well as on OBs and may, therefore, 
have effects on both lineages.   
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2.  Prostaglandins (PGs) – PGs are 20-carbon polyunsaturated fatty acids 
produced by many cell types.   Although OCs can produce PGs, the major 
source of PGs in bone is thought to be cells of the OB lineage. The production of 
PGs, especially PGE2, in OBs is stimulated by many resorption agonists (i.e., 
factors that increase the RANKL/OPG ratio), and PGE2 is itself a potent 
stimulator of OC formation [15, 16]   Hence, the effects of other resorption 
agonists may be modulated by their induction of PGE2.   
 
Regulation of PG Production 
Conversion of arachidonic acid (AA), derived from the cellular lipid bilayer, 
by cyclooxygenase (COX), also called prostaglandin endoperoxide synthase, is 
the committed step in PG synthesis [14] (Figure 2).  COX has two isoforms, 
COX-1 and COX-2, encoded by separate genes [14].  COX-1 is encoded by a 22 
kb gene with 11 exons and COX-2 is encoded by a 8 kb gene with 10 exons [14].  
Even though COX-1 and -2 are similar in their enzymatic mechanisms, their 
functional roles differ.  COX-1 is constitutively expressed in nearly all tissues 
(including OBs).  COX-1 is thought to produce the PGs responsible for 
“housekeeping” functions such as the maintenance of renal blood flow, platelet 
aggregation and gastric cytoprotection [17].  In contrast, COX-2 is inducible, and 
is responsible for acute PG responses [18].  COX-2 is induced in response to 
multiple factors, including cytokines and growth factors (IL-1, TNF-α, TGF-α, 
TGF-β), hormones (parathyroid hormone, 1,25(OH)2D3) and mechanical loading 
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of bone [19-21].  The induction of COX-2 is generally transient in most cells, with 
a return to baseline in 24-48 hours [14]. 
Non-steroidal anti-inflammatory drugs (NSAIDs) like acetylsalicylic acid 
(aspirin) and ibuprofen act to inhibit PG production by preventing binding of AA to 
the catalytic site in both COX-1 and COX-2.  Newer NSAIDs, such as celecoxib 
(Celebrex), are selective for COX-2 [14].   
  
PGE2 and OC Formation 
PGE2 can stimulate OC differentiation in various types of in vitro cultures 
and bone resorption in bone cultures [14]    Studies have shown that PGE2 can 
indirectly increase osteoclastogenesis by increasing RANKL and decreasing 
OPG in OBs and can have direct stimulatory effects on the hematopoietic lineage 
to increase OC numbers as well [14].  On the other hand, other studies have 
reported that PGE2 can inhibit the activity of mature OCs [22].  One study 
reported both inhibitory and stimulatory effects of PGE2 on OC formation in 
hematopoietic lineage cells [8].  Hence, the effects of PGE2 on OC formation and 
activity can be complex, perhaps in part because there are so many different 
model systems in which to study OC formation.   
 
3.  Models for Studying Osteoclast Formation – A number of different murine 
models to study osteoclastogenesis have developed over the years. All of them 
require the addition of some “resorption” agonist (some stimulator of RANKL) or 
the addition of RANKL itself.  Some systems examine effects of indirect actions 
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of resorption agonists on OC formation, while others examine direct effects on 
the hematopoietic lineage.    
 
Bone Marrow Cultures 
Bone marrow contains cells of both the hematopoietic and mesenchymal 
lineage.  Hence, under appropriate conditions, whole bone marrow can be used 
to study either osteoblastic differentiation (called bone marrow stromal cell 
cultures) or osteoclastic differentiation (simply called bone marrow cultures).  
Although cells of the osteoblastic lineage make M-CSF, RANKL, and OPG, there 
is not enough RANKL made under basal culture conditions to stimulate OC 
formation.  Hence, to differentiate OCs from bone marrow requires the addition of 
agonists that can increase RANKL production by cells of the mesenchymal 
lineage [23-25].  There cultures are generally used to assess the ability of various 
resorption agonists to stimulate the RANKL/OPG ratio and compare with 
numbers of OCs formed.  Although these cultures do not require 
supplementation with either RANKL or M-CSF, addition of RANKL to these 
cultures can be examined to determine the maximal number of cells with the 
potential to develop into OCs. 
In marrow cultures, PGE2 generally stimulates OC differentiation by 
increasing RANKL and inhibiting OPG [24].  Since many resorption agonists also 
induce COX-2 in these cultures, some of the ability of these agonists to induce 
OC formation is dependent on their induction of PGs.  This has been shown by 
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treating these cultures with NSAIDs to inhibit PG production or by using cells 
from COX-2 knockout mice [24].   
 
Spleen Cultures 
Spleen cultures contain precursor OCs and no OB precursors.  Therefore, 
these cultures can be used to examine direct effects of agonists on OC 
precursors.   Since there are no osteoblastic cells present, the cultures require 
supplementation with M-CSF and soluble RANKL.  If one wants to study the 
contribution of mesenchymal cells from one type of transgenic mouse and 
hematopoietic cells from another type, then co-cultures combining OBs from one 
type of transgenic mouse with spleen cells from another type can be used.  
It has been shown that PGE2 can increase the combined effects of 
RANKL and M-CSF to stimulate OC formation in some spleen cultures [25, 26].  
For example, our lab found that there was a 50% reduction in OCs formed in the 
presence of RANKL and M-CSF when the spleen cells came from COX knockout 
mice [24].  This was explained as being  due to increased expression of 
granulocyte monocyte-colony stimulating factor (GM-CSF), an inhibitor of OC 
formation, in COX-2 knockout spleen cultures [26].  However, that study 
measured OC formation only at one time point.  In another study where OC 
formation was examined over multiple time points, we found that PGE2, in the 
presence of RANKL and M-CSF, had biphasic effects on OC formation [26].  
PGE2 decreased the number of OCs at 5-6 days of culture but increased the 
number of OCs at 8-9 days compared with cultures treated with RANKL and M-
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CSF alone [24].  The increase in OC number at the later time point may have 
been due to the observation that PGE2 decreased OC apoptosis at day 7.  It was 
concluded that PGE2 has an initial inhibitory effect on OC formation in spleen cell 
cultures and a later stimulatory effect mediated by the EP2 receptor [24].  Spleen 
cultures also contain T cells, and it was speculated that the T cells were 
responsible for the initial inhibitory effects of PGE2 on osteoclastogenesis in this 
system.  Hence, both stimulatory and inhibitory effects of PGE2 on OC formation 
have been seen in spleen cultures.  
 
Peripheral Blood Mononuclear Cells (PBMCs) 
 PBMCs are a subset of white blood cells having a round nucleus, such as 
a lymphocyte or a monocyte, that can give rise to OCs in culture when treated 
with RANKL and M-CSF.  The advantage of PBMCs above other cells is that 
blood is a readily accessible cellular material, and PBMCs can be isolated from 
whole blood relatively easily. Various studies have shown that PBMCs can 
display gene expression patterns characteristic for certain diseases, such as 
acute myeloid leukemia, atherosclerosis, and autoimmune diseases [27].   
  The effects of PGE2 on human OC formation were examined in cultures 
of CD14+ cells prepared from human PBMCs [28].  PGE2 in the presence of 
RANKL and M-CSF inhibited OC formation in these cultures.  The conditioned 
medium of CD14+ cells pretreated with PGE2 inhibited RANKL-induced OC 
formation not only in human CD14+ cell cultures but also in mouse macrophage 
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cultures. The authors concluded that PGE2 inhibits human OC formation in 
PBMC cultures through the production of an as yet unknown inhibitory factor. 
 
RAW 264.7 Cultures 
RAW264.7 cells are the only known clonal cell line that can give rise to 
OCs in vitro.  The RAW 264.7 cell line is a functional murine macrophage cell line 
transformed by the Abelson Leukemia Virus.  Hence, they may not reflect 
‘normal’ OC development.  These cells produce cytokines in response to 
lipopolysaccharide (LPS) and can make OCs in response to RANKL [29].  Since 
RAW 264.7 cells produce M-CSF, it is not necessary to add M-CSF to cultures.   
 Several studies have suggested that PGE2 can enhance 
osteoclastogenesis in the RAW 264.7 cell line [29].  On the other hand, a study in 
our lab examining OC formation in RAW 264.7 cells treated with tumor necrosis 
factor (TNF-α) found that inhibition of PGE2 production in these cultures 
stimulated the formation of OC [30].  
 
Bone Marrow Macrophage Cultures 
Bone marrow macrophages (BMMs) are primary macrophages/monocytes 
isolated from bone marrow that can be differentiated into OCs [31-38].   BMMs 
are expanded in M-CSF and then treated with RANKL to stimulate OC formation.  
Compared to many other primary cells, BMMs are relatively homogenous, have a 
proliferative capacity, are transfectable, and have a lifespan longer than a week. 
In fact, BMMs can be grown up to three weeks without noticeable cell death or 
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altered morphology [39].  There is little known regarding the effects of PGE2 on 
BMM cell cultures.   
 
4.  OC Quantification 
Quantitative assessment of OC numbers are essential to allow statistical 
comparisons between treatment groups, and to facilitate reference databases for 
the study of metabolic bone diseases associated with increased bone resorption. 
Some methods have included scoring systems to evaluate TRAP staining 
intensity [40], and grid systems to evaluate TRAP distribution [41], however, 
TRAP levels are subjectively graded (e.g., 1 to 4) rather than actually quantifying 
cell numbers, stain density, or area percentages. Although many studies have 
provided valuable information regarding TRAP distribution and histomorphometry 
of resorbing cells, no study has offered a precise method for quantifying TRAP 
positive cells or OCs.   
With the development of faster computers and better cameras, more 
sophisticated forms of image analysis have been introduced allowing images 
from the microscope to be captured and transmitted to a computer equipped with 
image analysis tools [41].  In our study, we will use digital imaging and 
computers, to standardize the size and location of the region of interest, quantify 
the positive OC staining area, document the reproducibility of the measurements, 
create a permanent record of the OC wells of interest, and demonstrate a direct 
correlation with the current "gold standard" of OC quantification performed 
directly under a microscope. 
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5. Bone Resorption, PGs and Orthodontic Tooth Movement 
Tooth movement is a coordinated array of events involving bone 
resorption and formation.  The efficiency of bone resorption is the rate-limiting 
factor in tooth movement [41-44].  Bone is removed in front of the moving tooth 
by two mechanisms: frontal resorption at the periodontal ligament (PDL) interface 
and initial remodeling events (resorption cavities) in the cortical plate [45, 46].  
Orthodontic force initiates a cascade of cellular proliferation and differentiation 
events in the PDL [47-51].  A variety of neurological, immune, and endocrine 
system responses, as well as local cytokines and intracellular messages, have 
been implicated in the osseous adaptive reaction as the root of the tooth is 
displaced [52].  These localized agents are likely mediators of the temporary 
discomfort noted during the initiation of orthodontic tooth movement.  The role of 
local cytokines in the sustained bone modeling and remodeling events of tooth 
movement is largely unknown. However, PGs are thought to be important factors 
in the control of mechanically mediated bone adaptation [53]. 
Among other factors, the removal of osseous tissue during progressive 
tooth movement is directly related to the resorption rate and to OC recruitment.  
The OC resorption rate is largely controlled by metabolic factors [54].  There is 
currently no direct evidence to suggest that OCs are produced in the PDL.  Pre-
OCs can be  derived from the bone marrow, enter the circulation and 
subsequently be delivered to the PDL and adjacent bone [14].  It has been 
shown that PDL cells also require cell-to-cell contact to stimulate 
osteoclastogenesis [55].  During the application of orthodontic forces, RANKL 
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has been seen in OBs, osteocytes, and fibroblasts [55].  Also, the RANKL/OPG 
ratio has been implicated in root resorption associated with heavy orthodontic 
forces applied in rats [56].   
PGs are potent stimulators of bone resorption, and have been shown to 
be produced when teeth are mechanically loaded and to enhance tooth 
movement [14, 17].  For example Yamasaki et al [55] showed that orthodontic 
mechanical stress induced secretion of PGs in the periodontal tissues of rats 
stimulated OC bone resorption.  When PGE1 or PGE2 were injected in the 
gingiva near the upper first molar in rats, OCs and alveolar bone resorption were 
observed [23, 57, 58].  On the other hand, the administration of indomethacin, an 
inhibitor of PG production, suppressed the appearance of OCs and bone 
resorption. Indomethacin also decreased the extent of resorption surfaces in 
response to orthodontic loading in miniature pigs [59].  Orthodontic forces have 
also been shown to increase cytokine production, such as TNF-α and IL-1, which 
can induce COX-2 expression and PG production in OBs and in cultured bone 
marrow cells [28].  Although these cytokines are themselves potent inducers of 
bone resorption, some of their effects on resorption may be mediated via their 
induction of COX-2 and PGs [26].  
 
 
 
 
 
  13 
RATIONALE 
In order for tooth movement to occur, bone resorption has to take place on 
the compression side followed by bone deposition on the tension side.  Thus, 
OCs play a crucial role in tooth movement.  Although PGs have been shown to 
enhance orthodontic tooth movement, it is unclear if this enhancement involves 
not only PG stimulation of the RANKL/OPG ratio in OC supporting cells (PDL 
cells and/or OBs) but also stimulatory effects on cells of the osteoclast lineage.  
As discussed above, the effect of PGE2 to increase RANKL/OPG is well 
documented, but PGE2 has been shown to have both stimulatory and inhibitory 
effects on OC formation in different models used to study OC formation.   One 
explanation for the differences seen in studies of the direct effects of PGE2 on 
OC precursors may be the time points at which OC formation was quantified.  In 
spleen cell cultures studied over an extensive time course, PGE2 had biphasic 
effects, an initial inhibitory effect on OC formation with a later stimulatory effect 
[60]. Preliminary data from our lab, studying OC formation in cultured BMMs also 
suggest that PGE2 may have inhibitory effects.  One of the difficulties with 
studying BMMs is that very large numbers of OCs are formed, making counting 
under the microscope tedious, time-consuming, and operator dependent.  The 
goals of this project were to develop a digital method of recording OC counts and 
to use this method to examine the effects of PGE2 on OC formation from purified 
BMMs in the presence of RANKL and M-CSF over an extended time course.     
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HYPOTHESIS 
1. Digital imaging will strongly correlate with the conventional method of OC 
quantification. 
 
2. PGE2 will inhibit or delay OC formation in BMM cultures. 
 
 
 
OBJECTIVES 
The overall objective of this research was to clarify the effects of PGE2 on 
OC formation in BMM cultures.  The specific objectives were:  
 
1. To create a method that permitted convenient quantification of large 
numbers of OCs. 
 
2. To examine the effects of exogenous PGE2 on the differentiation of OC 
precursors into OCs in BMM cultures. 
 
a) Examine the effects of a dose response of PGE2 on BMM cells. 
 
b) Examine the time course for effects of PGE2 on BMM cells. 
 
 
  15 
MATERIALS AND METHODS 
1. Materials 
 RANKL and M-CSF were obtained from R&D Biosystems (Minneapolis, 
MN).  PGE2 was obtained from Cayman Chemical Company (Ann Arbor, MI). 
Minimal Essential Medium Alpha (α-MEM), fetal calf serum (FCS), and 
trypsin/EDTA were purchased from Invitrogen (Carlsbad, CA).  Leukocyte Acid 
Phosphatase Kit (TRAP stain) was purchased from Sigma (St. Louis, MO).   
 
2. Bone Marrow Macrophage (BMM) Cultures 
Isolation of BMMs 
 All animals used in this study were treated in accordance with protocols 
approved by the Animal Care and Use Committee of the University of 
Connecticut Heath Center. Long bones (femur and tibia) of 8 week old CD1 mice 
(males and females) were dissected free of adherent tissue and placed into 
sterile dishes on ice.  Bone marrow was flushed with alpha MEM (without serum) 
under the hood using syringes with 25 gauge needle (1ml per bone).  The bone 
marrow cells were then resuspended in alpha MEM + 10% FCS + 100 ng/ml M-
CSF and plated at 5X106 cells per/well in 100 mm petri dish (Fisher brand 08-
757-12).  Adherent cells, the bone marrow macrophages (BMMs), were lifted 
after 3 days with trypsin/EDTA, centrifuged and  resuspended in alpha MEM 
+10% FCS + 30 ng/ml MCSF and 100 ng/ml RANKL and plated in either 48 or 96 
well dishes for osteoclastogenesis experiments. 
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Osteoclastogenesis 
 5,000 cells/well were plated in 96 well plates and 15,000 cells/well in 48 
well plates.  The media, which consisted of alpha MEM +10% FCS + 30 ng/ml M-
CSF and 60 or 100 ng/ml RANKL, was changed every 2-3 days.  Cells were 
cultured for a time course of 4-9 days, depending on the experiment.  The cells 
were also subjected to different concentrations of PGE2, either 10-6 M or 10-8 M.  
Please see individual experiments under ‘Results’ section for exact time course 
and PGE2 concentrations for each individual experiment.   
  
Expansion  
 Left over BMMs were expanded at 5X106 cells per/well in 100 mm petri 
dish in alpha MEM +10% FCS + 100 ng/ml M-CSF for future osteoclastogenesis 
experiments. 
 
3. Tartrate Resistant Acid Phosphatase (TRAP) Staining 
Cells were fixed at the end of culture with 2.5% glutaraldehyde.  A 
Leukocyte Acid Phosphatase Kit was used to stain for TRAP following the 
manufacturer’s instructions.  The TRAP positive multinucleated cells (MNCs), 
with 3 or more nuclei, were either directly counted under the microscope at 20X 
total magnification or indirectly counted via digital imagery at 20X total 
magnification. 
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4. OC Quantification 
Direct OC Quantification  
 The TRAP stained plates were placed under a high power light 
microscope (Olympus IX70, Melville, New York) and viewed at 20X total 
magnification.  Due to the high power magnification needed to view the OCs 
nuclei, it was not possible to view the entire well under one field of view.  In order 
to view the entire well, the built in eyepiece grid was used to ensure proper 
tracking of the well during quantification.  Each TRAP positive cell with 3 or more 
nuclei was counted using a handheld click counter.  An OC tally of each well from 
each plate was recorded and graphed. 
 
Indirect OC Quantification  
 The TRAP positive plates were placed under a high power light 
microscope (Nikon Eclipse TE2000-U, Tokyo, Japan) and viewed at 20X total 
magnification.  The microscope was connected to a digital camera (Spot RT 
Slider, Diagnostic Instruments, Sterling Heights, MI) and the images were 
captured using Windows Spot Advanced software version 4.1 (Diagnostic 
Instruments, Sterling Heights, MI).  Due to the high power magnification needed 
to view the OCs nuclei, it was not possible to view the entire well under one field 
of view.  Multiple images were merged into one complete and seamless image 
using Adobe Photoshop CS2 (Adobe Systems Incorporated, San Jose, CA), 
printed using a photo quality color printer, Hewlett-Packard Color Laser Jet 
4700dn (Hewlett-Packard, Palo Alto, CA), and the OCs were quantified.     
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5. Design Overview 
 
 
 
6. Statistical Analysis 
All values are depicted as the mean ± standard error of the mean (SEM). 
Statistical analysis was performed using GraphPad Prism® for Microsoft 
Windows®, version 4.0 (GraphPad Software, La Jolla, CA).  To compare multiple 
treatment groups, differences were examined by two-way analysis of variance 
(ANOVA) followed by the Bonferroni test.  
 
 
 
 
 
 
Bone Marrow Macrophage Isolation 
Bone Marrow Macrophage Expansion 
Osteoclastogenesis Continue Bone Marrow Macrophage 
Expansion (up to 4 passages) 
Fix and Stain Osteoclasts 
Osteoclast Quantification 
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RESULTS 
1. Comparison of Direct and Indirect OC Quantification 
Our first goal of this project was to create a method that will permit a 
reliable and convenient quantification of large numbers of OCs.  The wells of 48 
well plates were divided into sextants, and six different images of the same well 
were captured and later pieced back together to create one seamless image 
(Figure 3).  The wells of 96 well plates were divided in half, and two different 
images of the same well were captured and later pieced back together to create 
one seamless image (Figure 4).  The images were then printed and the OCs 
counted.   
Only ‘normal’ and ‘healthy’ appearing multinucleated TRAP positive cells 
were counted.  ‘Ghost’ cells, cells with degraded membranes, or cells with less 
than 3 nuclei were not quantified (Figure 5). 
Following the protocol listed above, a correlation between direct (directly 
under the light microscope) OC quantification and indirect (using the digital 
photography method) OC quantification was compared (Figure 6, Table 1) and 
graphed (Figure 7).  The results of the correlation experiments showed a 99.81% 
correlation between the direct and indirect quantification of OC counts (Figure 7).  
Since the indirect quantification method has many advantages over the direct 
method, all the remainder of our experiments were quantified using the indirect 
method.   
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2. Effects of PGE2 on OC Formation 
The second aim was to examine the direct effects of exogenous PGE2 on the 
differentiation of OCs in BMM cultures.  For these experiments, we added PGE2 
to BMM cells from CD1 mice, in the presence of M-CSF and RANKL, and 
observed OC formation.  We did a total of six experiments.  Since we found that 
the size of the wells in the dishes used affected the results, we have divided the 
experimental results according to the size of the wells.  
 
Effects of PGE2 using 48 well plates 
Experiment 1 was done in 48 well dishes (Table 2, Fig. 8).  Cultures were 
treated with M-CSF (30 ng/ml) and RANKL (100 ng/ml), with and without PGE2 
(10-6 M). OCs were counted on days 5, 6, 7, and 8.  OC counts peaked at day 7 
for both control (RANKL and M-CSF) and treatment (PGE2) groups.  PGE2 
decreased the peak OC count by 84%.   
Experiment 2 was also done in 48 well dishes (Table 3, Fig. 9).  Cultures 
were treated with M-CSF (30 ng/ml) and RANKL (100 ng/ml), with and without 
PGE2 (10-6 M or 10-8 M).  OCs were counted on days 6, 7, 8 and 9.  OC counts 
for the control group peaked at day 7.  OC number in the PGE2 10-8 M group 
peaked at day 8.  OC number in the PGE2 10-6 M group showed a slow steady 
increase without a true peak.  For both treatments, PGE2 had an inhibitory effect 
on OC formation, with PGE2 10-6 M being more inhibitory than PGE2 10-8 M.  
PGE2 10-8 M decreased the peak OC count by 36% and PGE2 10-6 M decreased 
the peak OC count by 93%.   
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Experiment 3 was also done in 48 well dishes (Table 4, Fig. 10).  Cultures 
were treated with M-CSF (30 ng/ml) and RANKL (100 ng/ml), with and without 
PGE2 (10-6 M or 10-8 M).  OCs were counted on days 5, 6, 7, 8 and 9.  OC counts 
for the control group and the PGE2 10-8 M group both peaked on day 7, while OC 
numbers for the PGE2 x 10-6 M group peaked at day 8.  PGE2 had an inhibitory 
effect on OC formation, with PGE2 X 10-6 M being more inhibitory than PGE2 10-8 
M.  Peak OC count was decreased by 14% in the PGE2 10-8 M group and by 
41% in the PGE2 10-6 M group.    
 
Effects of PGE2 using 96 well plates 
Experiment 4 was done in 96 well dishes (Table 5, Fig. 11).  Cultures were 
treated with M-CSF (30 ng/ml) and RANKL (60 ng/ml), with and without PGE2 
(10-6 M or 10-8 M).  This was the only experiment where 100 ng/ml of RANKL was 
not used.  OCs were counted on days 6, 7, 8 and 9.  OC counts for all 3 groups 
peaked at day 7.  Both PGE2 groups had a stimulatory effect on OC formation, 
with PGE2 10-8 M being more stimulatory than the PGE2 10-6 M group.  PGE2 10-8 
M increased the peak OC count by 89% and PGE2 10-6 M increased the peak OC 
count by 36.7%.    
Experiment 5 was also done in 96 well dishes (Table 6, Fig. 12).  Cultures 
were treated with M-CSF (30 ng/ml) and RANKL (100 ng/ml), with and without 
PGE2 (10-6 M).  OCs were counted on days 4, 5, 6, and 7.  There was no 
appreciable difference in OC counts at days 4 and 5, for the control group or the 
PGE210-6 M group.  At later time points, however, PGE2 had a stimulatory effect 
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(days 6, and 7.)  Thus, our conclusion from this experiment was that PGE2 10-6 M 
had a no effect early on leading to a later stimulation of OCs.      
 Experiment 6 was also done in 96 well dishes (Table 7, Fig. 13).  Cultures 
were treated with M-CSF (30 ng/ml) and RANKL (100 ng/ml), with and without 
PGE2 (10-6 M).  OCs were counted on days 4, 5, 6, and 7.  OC counts peaked at 
day 5 for both the control group and the PGE2 10-6 M group.  In this experiment, 
PGE2 10-6 M had an initial inhibitory effect, and a later stimulatory effect.  Thus, 
our conclusion from this experiment was that PGE2 10-6 M had a biphasic effect.   
 Please see Table 8 for the overall experimental results for all 6 
experiments.   
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DISCUSSION 
We developed an “indirect” method for quantifying OC numbers.  Multiple 
high power fields were photographed and merged together to give prints of whole 
wells of cells.  This method of counting OCs showed a 99.8% correlation with the 
direct counting of OC under a microscope.   It also gave us a hard copy of the 
data that could be filed for later review by other investigators. 
The experiments to study effects of PGE2 on OC formation were 
unexpectedly complicated by finding that results varied with size of the well used 
to culture OCs.  Three independent experiments using 48 well dishes showed 
that PGE2 had an inhibitory effect on osteoclastogenesis.  The higher dose of 
PGE2 (10-6 M) was more inhibitory than the lower dose of PGE2 (10-8 M).  In 
these experiments, the peak OC number consistently occurred on day 7-8 in both 
control (RANKL + M-CSF) cultures and in PGE2-treated cultures.     
In contrast, the 96-well experiments had inconsistent results.  In these 3 
independent experiments the results showed: either stimulation, no effect leading 
to stimulation, or a biphasic effect with early inhibition and later stimulation.   The 
OC formation peaked at d 4, 5, or d 7.  Although effects of PGE2 on the formation 
of OCs from BMMs were variable in 96-well plates, PGE2 consistently inhibited 
OC formation in 48-well plates.  In addition, the higher dose of PGE2 (10-6 M) was 
less stimulatory than the lower dose of PGE2 (10-8 M). 
   We do not think that this variability is the result of plating density.  The 
48 and 96 well plates have surface growth areas of 0.95 cm2 and 0.32 cm2 
respectively.  The 48 well plates were plated with 15,000 cells per well, while the 
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96 well plates were plated with 5,000 cells per well.  Hence, our plating densities 
were similar at 15,600-15,800 cells per cm2.  However, there was a difference in 
the ratio of circumference to growth area in the dishes.  The 48 well plate has a 
3.45 cm circumference or 3.6 cm per cm2 of growth area, while the 96 well plate 
has a 2 cm circumference or 6.2 cm per cm2 of growth area.  There may be 
greater “edge effects” in the smaller well, such that more cells are sensing the 
well wall instead of other cells.  Interaction with the well wall might cause cells to 
react differently than if they were interacting with other cells  
 Others have also observed variability in these types of models to study 
OC formation.  One group of researchers had a similar situation to ours, so they 
performed 46 similar experiments for a time course of 26 days [60].  
Unexpectedly, they found that OC numbers changed in a manner much more 
complex than current knowledge could predict [60].  They observed synchronized 
waves of OC formation and death and OC oscillations [60].  In other words, when 
they cultured cells for a longer time period, they observed a second wave of OC 
formation after the first wave disappeared (i.e., all initial OCs had died).  They 
also observed that the second wave had a greater amplitude than the first [60].  
In several experiments, they even observed a third wave of OC formation, larger 
than the previous two waves.  They examined different plating densities but did 
not see an affect on the rate of OC formation.  However, they found that 
experiments performed with low concentration of RANKL (10 ng/ml) did not 
exhibit this oscillating OC formation pattern, and the experiment groups with a 
high concentration of RANKL (100 ng/ml) developed OCs with oscillatory 
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behavior more frequently [60].  They concluded that RANKL concentration, not 
plating density, significantly affects the probability of the experiment to exhibit 
oscillations in osteoclast number [60].   
 Five of our 6 experiments were done using a ‘high’ concentration of 
RANKL (100ng/ml).  Experiment 4 was also done using relatively ‘high’ 
concentration of RANKL (60ng/ml).  Perhaps our experiments were exhibiting the 
‘oscillations’ described above but we did not follow them long enough to see 
these oscillations.  It is possible that the effects of PGE2 were simply to delay, 
relative to the control cultures, the wave of OC formation, causing the PGE2 
treated wave to be offset from the control treated wave (Figure 14).  If this were 
the case, whether PGE2 caused stimulation, inhibition, or a biphasic event would 
simply depend on where the measurement was made relative to the positions of 
the control and PGE2 treated waves.  As can be seen from the hypothetical 
situation illustrated in Figure 14, the conclusion taken from the counts at days 4, 
5, and 6 would be that PGE2 has an inhibitory effect, while at day 7 there was no 
significant difference, and  at days 8, 9, and 10 PGE2 was stimulatory.  Whether 
or not this delay in OC formation will be important in vivo is not known.  It is 
unrealistic to have such micro-controlled environments for days to weeks at a 
time, when in vivo, these environments may last for only minutes to hours.  .   
 Clearly these data suggest that we should examine the effects of PGE2 on 
OC formation using lower doses of RANKL, where oscillations are not expected 
to occur. Further examination is needed to determine whether the size of the 
culture well produces a different outcome when plated at the same density.  The 
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effects of looking at cell growth rate and the age of the mice from which the 
BMMs were isolated may also be important factors in osteoclastogenesis that 
require further examination.   We would also like to develop mice that have COX-
2 deleted specifically from OC precursors.  We could then look at the resorption 
response in vivo to agents that stimulate resorption. 
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SIGNIFICANCE 
 Overall, our study provides new information about the quantification of 
OCs and the process of osteoclastogenesis by taking into account the dose 
response and time course associated with BMM cultures using PGE2.  Our study 
also highlights the difficulties in creating such models in a biologically accurate 
manner.  This study gives us a better understanding of the role of 
osteoclastogenesis and bone remodeling and its mechanism of action via PGs.  
It gives orthodontists greater insight into the mechanisms involved in stimulation 
and inhibition of tooth movement. This in turn could improve the quality and 
efficiency of treatment.  
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TABLES 
 
Direct Microscope Count 
Solution  
Day 
6a 
Day 
6b 
Day 
7a 
Day 
7b 
Day 
8a 
Day 
8b 
Day 
9a 
Day 
9b 
M 0 0 0 0 0 0 0 0 
M + R 665 543 754 829 531 648 338 237 
M + PGE2 -6 M 0 0 0 0 0 0 0 0 
M + R + PGE2 -6 M  12 21 50 47 44 57 51 62 
M + PGE2 -8 M 0 0 0 0 0 0 0 0 
M + R + PGE2 -8 M 213 203 361 318 565 520 236 238 
 
Indirect Digital Photo Count 
Solution 
Day 
6a 
Day 
6b 
Day 
7a 
Day 
7b 
Day 
8a 
Day 
8b 
Day 
9a 
Day 
9b 
M 0 0 0 0 0 0 0 0 
M + R 769 638 866 942 609 754 385 278 
M + PGE2 -6 M 0 0 0 0 0 0 0 0 
M + R + PGE2 -6 M  11 19 48 44 46 54 53 68 
M + PGE2 -8 M 0 0 0 0 0 0 0 0 
M + R + PGE2 -8 M 247 184 419 368 593 565 266 266 
 
Table 1:  Osteoclast (OC) counts: comparison of direct and indirect quantification 
methods.  
 
 
 
Indirect Digital Photo Count for Experiment #1 
Solution 
Day 
5a 
Day 
5b 
Day 
6a 
Day 
6b 
Day 
7a 
Day 
7b 
Day 
8a 
Day 
8b 
M 0 0 0 0 0 0 0 0 
M + R 207 227 462 536 621 697 396 403 
M + PGE2 -6 M 0 0 0 0 0 0 0 0 
M + R + PGE2 -6 M  35 57 45 68 107 104 64 59 
 
Table 2: OC quantification for Experiment 1. 
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Indirect Digital Photo Count for Experiment #2 
Solution 
Day 
6a 
Day 
6b 
Day 
7a 
Day 
7b 
Day 
8a 
Day 
8b 
Day 
9a 
Day 
9b 
M 0 0 0 0 0 0 0 0 
M + R 769 638 866 942 609 754 385 278 
M + PGE2 -6 M 0 0 0 0 0 0 0 0 
M + R + PGE2 -6 M  11 19 48 44 46 54 53 68 
M + PGE2 -8 M 0 0 0 0 0 0 0 0 
M + R + PGE2 -8 M 247 184 419 368 593 565 266 266 
 
Table 3:  OC quantification for Experiment 2. 
 
 
 
Indirect Digital Photo Count for Experiment #3 
Solution Day 5a Day 5b Day 5c Day 6a Day 6b Day 6c 
M+R 50 32 44 146 126 147 
M+R+PGE2 -6 M 5 3 3 15 30 29 
M+R+PGE2 -8 M 27 22 23 96 103 83 
        
Solution Day 7a Day 7b Day 7c Day 8a Day 8b Day 8c 
M+R 272 303 316 249 287 223 
M+R+PGE2 -6 M 77 75 74 152 183 191 
M+R+PGE2 -8 M 263 247 256 224 241 222 
        
Solution Day 9a Day 9b Day 9c    
M+R 101 106 91    
M+R+PGE2 -6 M 34 63 49    
M+R+PGE2 -8 M 86 91 103    
 
Table 4:  OC quantification for Experiment 3. 
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Indirect Digital Photo Count for Experiment #4 
Solution 
Day 
6a 
Day 
6b 
Day 
6c 
Day 
6d 
Day 
7a 
Day 
7b 
Day 
7c 
Day 
7d 
M 0 0 0 0 0 0 0 0 
M+R 61 54 35 35 233 159 191 187 
M+PGE2 -6 M 0 0 0 0 0 0 0 0 
M+R+PGE2 -6 M 88 61 72 68 239 274 263 277 
M+PGE2 -8 M 0 0 0 0 0 0 0 0 
M+R+PGE2 -8 M  76 97 83 126 442 323 339 351 
         
Indirect Digital Photo Count for Experiment #4 
Solution 
Day 
8a 
Day 
8b 
Day 
8c 
Day 
8d 
Day 
9a 
Day 
9b 
Day 
9c 
Day 
9d 
M 0 0 0 0 0 0 0 0 
M+R 47 26 27 26 39 17 19 35 
M+PGE2 -6 M 0 0 0 0 0 0 0 0 
M+R+PGE2 -6 M 176 165 232 210 111 97 112 88 
M+PGE2 -8 M 0 0 0 0 0 0 0 0 
M+R+PGE2 -8 M  62 57 35 35 33 39 37 32 
 
Table 5:  OC quantification for Experiment 4. 
 
 
 
Indirect Digital Photo Count for Experiment #5 
Solution 
Day 
4a 
Day 
4b 
Day 
4c 
Day 
5a 
Day 
5b 
Day 
5c 
M + R 117 137 148 78 136 133 
M + R + PGE2 -6 M 162 102 105 137 128 117 
       
Indirect Digital Photo Count for Experiment #5 
Solution 
Day 
6a 
Day 
6b 
Day 
6c 
Day 
7a 
Day 
7b 
Day 
7c 
M + R 13 21 19 21 22 19 
M + R + PGE2 -6 M 45 106 120 41 45 57 
 
Table 6:  OC quantification for Experiment 5. 
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Indirect Digital Photo Count for Experiment #6 
Solution 
Day 
4a 
Day 
4b 
Day 
4c 
Day 
5a 
Day 
5b 
Day 
5c 
M + R 83 59 73 101 90 71 
M + R + PGE2 -6 M 16 24 16 66 33 54 
       
Indirect Digital Photo Count for Experiment #6 
Solution 
Day 
6a 
Day 
6b 
Day 
6c 
Day 
7a 
Day 
7b 
Day 
7c 
M + R 17 17 4 12 8 6 
M + R + PGE2 -6 M 32 59 48 17 35 31 
 
Table 7:  OC quantification for Experiment 6. 
 
 
 
Biphasic (I  S)966
No Effect S965
Stimulation 964
Inhibition483
Inhibition482
Inhibition481
PGE2 Effect on OC 
FormationWell SizeExperiment #
Overall Experimental Results
 
Table 8: Overall Experimental Results.  
Inhibition (I) – The Total OC counts of the experiment group (group with PGE2) 
was less than the control group (group without PGE2). 
Stimulation (S) – The total OC counts of the experiment group (group with PGE2) 
was more than the control group (group without PGE2). 
No Effect  S – The experiment group and control groups showed no 
appreciable difference between OC counts at early time points.  At later time 
points, the experiment group showed stimulation.   
Biphasic (I  S) – When the experiment group showed inhibition at early time 
points and stimulation at later time points.   
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FIGURES 
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Figure 1: Osteoclast (OC) differentiation pathway. 
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Figure 2: Arachidonic acid (AA) metabolic pathway leading to the production of 
prostaglandins (PG). 
Cyclooxygenase 
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Individual photos Photo Merge
a. b.
 
Figure 3:  48 well photo merge.  a) The wells of 48 well plates were divided into 
sextants, and six different images of the same well were captured. b) 
Reconstruction of 48 well dish creating one seamless image. 
 
 
 
 
Individual photos Photo Merge
a. b.
 
Figure 4:  96 well photo merge.  a) The wells of 96 well plates were divided in 
half and two different images of the same well were captured. b) Reconstruction 
of 96 well dish creating one seamless image. 
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a
b
c
 
Figure 5:  Expanded view of an experimental well.  a) “Normal” healthy looking 
OC with multiple nuclei.  b) “Ghost” OC showing complete degradation of the cell 
membrane. c) TRAP positive OC showing partial cell membrane degradation and 
cell fragments.  Note: only “Normal” appearing OCs were quantified. ‘Ghost’ 
cells, cells with degraded membranes, or cells with less than 3 nuclei were not 
quantified.  Cells b and c would not be quantified.   
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M + R + PGE2 x 10 -8 M
M + PGE2 x 10-6 M
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Day 6 Day 7 Day 8 Day 9
 
 
Figure 6: Tartrate resistant acid phosphatase (TRAP) stained bone marrow 
monocyte/macrophage (BMM) cells from CD-1 mice.  BMM Cells from CD1 mice 
were cultured with macrophage-colony stimulating factor (M-CSF or M), receptor 
activator of NF-κB ligand (RANKL or R), and different PGE2 concentrations over 
a 4 day time course.  Cultures were TRAP stained and TRAP positive 
multinucleated cells (MNC) were directly counted under a light microscope and 
indirectly counted using the digital photography method.  The results were 
charted and graphed.  
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Figure 7: Correlation of OC counts using the direct and indirect methods.  The 
black squares symbolize the actual OC counts from the direct and indirect 
quantification methods from each well.  The red line symbolizes a 100% 
correlation between the direct and indirect quantification method, which would 
yield a slope of 1.  A 99.81% correlation was found between the direct and 
indirect method. 
 
 
 
 
 
 
 
R2 = 0.9981,   Y=mX + b,   Y=1.139X – 2.137,   P <0.0001 
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Figure 8: Experiment 1: Effect of PGE2 on OC formation in BMMs cultured in 48 
well dishes treated with M-CSF (M, 30 ng/ml), RANKL (R, 100 ng/ml), and in the 
presence or absence of PGE2 (10-6 M) for 5-8 days.  Cultures were TRAP 
stained, and TRAP positive MNC cells were counted using the digital 
photography method.  No TRAP positive MNCs were observed in cultures 
without RANKL. Symbols are means ±SEM for n=3 wells.  a Significant effect of 
PGE2, p<0.001; b p<0.01  
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Figure 9: Experiment 2: Effect of PGE2 on OC formation in BMMs cultured in 48 
well dishes treated with M-CSF (M, 30 ng/ml), RANKL (R, 100 ng/ml), and in the 
presence or absence of PGE2 (10-6 M or 10-8 M) for 6-9 days.  Cultures were 
TRAP stained, and TRAP positive MNC cells were counted using the digital 
photography method.  No TRAP positive MNCs were observed in cultures 
without RANKL. Symbols are means ±SEM for n=3 wells.  a Significant effect of 
PGE2 p<.001.  d Significantly different from PGE2 x 10-8, p<.001; e p<.01.    
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Figure 10: Experiment 3: Effect of PGE2 on OC formation in BMMs cultured in 48 
well dishes treated with M-CSF (M, 30 ng/ml), RANKL (R, 100 ng/ml), and in the 
presence or absence of PGE2 (10-6 M or 10-8 M) for 5-9 days.  Cultures were 
TRAP stained, and TRAP positive MNC cells were counted using the digital 
photography method.  No TRAP positive MNCs were observed in cultures 
without RANKL. Symbols are means ±SEM for n=3 wells.  a Significant effect of 
PGE2, p<.001, b p<.01.  d Significantly different from PGE2 x 10-8, p<.001.     
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Figure 11: Experiment 4: Effect of PGE2 on OC formation in BMMs cultured in 96 
well dishes treated with M-CSF (M, 30 ng/ml), RANKL (R, 60 ng/ml), and in the 
presence or absence of PGE2 (10-6 M or 10-8 M) for 6-9 days.  Cultures were 
TRAP stained, and TRAP positive MNC cells were counted using the digital 
photography method.  No TRAP positive MNCs were observed in cultures 
without RANKL. Symbols are means ±SEM for n=3 wells.  a Significant effect of 
PGE2, p<.001; c p<.05.  d Significantly different from PGE2 x 10-8, p<.001.  
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Figure 12: Experiment 5: Effect of PGE2 on OC formation in BMMs cultured in 96 
well dishes treated with M-CSF (M, 30 ng/ml), RANKL (R, 100 ng/ml), and in the 
presence or absence of PGE2 (10-6 M) for 4-7 days.  Cultures were TRAP 
stained, and TRAP positive MNC cells were counted using the digital 
photography method.  No TRAP positive MNCs were observed in cultures 
without RANKL. Symbols are means ±SEM for n=3 wells.  b Significant effect of 
PGE2,p<.01.   
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Figure 13: Experiment 6: Effect of PGE2 on OC formation in BMMs cultured in 96 
well dishes treated with M-CSF (M, 30 ng/ml), RANKL (R, 100 ng/ml), and in the 
presence or absence of PGE2 (10-6 M) for 4-7 days.  Cultures were TRAP 
stained, and TRAP positive MNC cells were counted using the digital 
photography method.  No TRAP positive MNCs were observed in cultures 
without RANKL. Symbols are means ±SEM for n=3 wells.  a Significant effect of 
PGE2, p<.001; b p<.01.   
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Figure 14: Hypothetical PGE2 experiment showing phase shift of OC counts and 
OC production.  This hypothetical situation illustrates that there is no difference in 
OC cycle or the long term effects on OC counts from PGE2, rather, just a shift in 
the OC production phase.  Note, OC counts at days 4, 5, and 6 would indicate 
PGE2 inhibits OC formation, at day 7 there is no significant difference, while at 
days 8, 9, and 10 PGE2 stimulates OC formation. 
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